Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01450969 · ClinicalTrials.gov registry record
New Fabric Attenuation Device in Endovascular Interventional Radiology (PREFER)
A clinical trial, sponsored by Baptist Health South Florida.
- Completed
- Registry status
- 60
- Enrollment target
NCT01450969: Completed study, sponsored by Baptist Health South Florida.
NCT01450969 is a clinical trial that has completed, run by Baptist Health South Florida. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01450969 has completed, sponsored by Baptist Health South Florida.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The PREFER Trial primary objective of the trial is to show how much radiation attenuation is provided by XPF in absolute and relative terms.
Primary Outcome
The null hypothesis is that the XPF thyroid collar is inferior to the standard 0.5mm Pb lead equivalent thyroid collar with regard to radiation attenuation/transmission. The alternative hypothesis is that the XPF thyroid collar is non-inferior to the standard thyroid collar. If there is truly no difference between standard and XPF thyroid collars, then 60 patients are required to be 95% sure that the lower limit of a one-sided 95% confidence interval (or equivalently a 90% two-sided confidence i
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2011-09 |
| Est. Completion | 2011-12 |
What the finished NCT01450969 record still lists
NCT01450969 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01450969 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01450969 about?
NCT01450969 is a clinical study titled "New Fabric Attenuation Device in Endovascular Interventional Radiology (PREFER)". The PREFER Trial primary objective of the trial is to show how much radiation attenuation is provided by XPF in absolute and relative terms.
What is the current status of trial NCT01450969?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2011-09. Estimated completion is 2011-12.
Who is sponsoring clinical trial NCT01450969?
This trial is sponsored by Baptist Health South Florida, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia